A randomized, non-inferiority trial comparing two bivalent killed, whole cell, oral cholera vaccines (Euvichol vs Shanchol) in the Philippines-Reference-Cited by-同舟云学术

A randomized, non-inferiority trial comparing two bivalent killed, whole cell, oral cholera vaccines (Euvichol vs Shanchol) in the Philippines

Published:2015-11 Issue:46 Volume:33 Page:6360-6365
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Baik Yeong Ok^ORCID,Choi Seuk Keun,Olveda Remigio M.,Espos Roberto A.^ORCID,Ligsay Antonio D.,Montellano May B.,Yeam Jong Sun,Yang Jae Seung,Park Ju Yeon,Kim Deok Ryun,Desai Sachin N.,Singh Ajit Pal,Kim Ick Young,Kim Chan Wha,Park Sue-nie

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference17 articles.

1. The global burden of cholera;Ali;Bull World Health Org,2012

2. A randomized, placebo-controlled trial of the bivalent killed, whole-cell, oral cholera vaccine in adults and children in a cholera endemic area in Kolkata, India;Mahalanabis;PLoS One,2008

3. Safety and immunogenicity study of a killed bivalent (O1 and O139) whole-cell oral cholera vaccine Shanchol, in Bangladeshi adults and children as young as 1 year of age;Saha;Vaccine,2011

4. 5 year efficacy of a bivalent killed whole-cell oral cholera vaccine in KolkataIndia: a cluster-randomised, double-blind, placebo-controlled trial;Bhattacharya;Lancet Infect Dis,2013

5. Post-licensure deployment of oral cholera vaccines: a systematic review;Martin;Bull World Health Org,2014

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cholera emergency in Nigeria: urgent need for better vaccine access and public health action;Bulletin of the National Research Centre;2024-09-03

2. Coverage of Two-Dose Preemptive Cholera Mass Vaccination Campaign in High-Priority Hotspots in Shashemene, Oromia Region, Ethiopia;Clinical Infectious Diseases;2024-07-12

3. Antibacterial carbonic anhydrase inhibitors targeting Vibrio cholerae enzymes;Expert Opinion on Therapeutic Targets;2024-07-02

4. Cholera rages in Africa and the Middle East: A narrative review on challenges and solutions;Health Science Reports;2024-05

5. Safety and immunogenicity of the Euvichol-S oral cholera vaccine for prevention of Vibrio cholerae O1 infection in Nepal: an observer-blind, active-controlled, randomised, non-inferiority, phase 3 trial;The Lancet Global Health;2024-05